|
MAP2K2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.890400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.283000E-01 |
| Normal-vs-Stage2 |
8.845400E-01 |
| Normal-vs-Stage3 |
1.828610E-01 |
| Normal-vs-Stage4 |
3.361600E-01 |
| Stage1-vs-Stage2 |
8.448800E-01 |
| Stage1-vs-Stage3 |
2.817600E-01 |
| Stage1-vs-Stage4 |
3.258200E-01 |
| Stage2-vs-Stage3 |
4.000600E-01 |
| Stage2-vs-Stage4 |
4.195400E-01 |
| Stage3-vs-Stage4 |
8.225000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.849000E-01 |
| Normal-vs-AfricanAmerican |
2.360200E-01 |
| Normal-vs-Asian |
8.787600E-01 |
| Caucasian-vs-AfricanAmerican |
3.494800E-01 |
| Caucasian-vs-Asian |
9.576800E-01 |
| AfricanAmerican-vs-Asian |
8.355200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.331200E-01 |
| Normal-vs-Female |
7.964000E-02 |
| Male-vs-Female |
6.704100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.991000E-01 |
| Normal-vs-Extreme_Weight |
6.531600E-01 |
| Normal-vs-Obese |
2.939200E-01 |
| Normal-vs-Extreme_Obese |
2.720200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.468200E-01 |
| Normal_Weight-vs-Obese |
8.551600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.816800E-01 |
| Extreme_Weight-vs-Obese |
4.632200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.327200E-01 |
| Obese-vs-Extreme_Obese |
3.520400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.030500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.774200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.728600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.882240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.789900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.354200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.104800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.758800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.413830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.325600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.482200E-01 |
| Normal-VS-Type2 PRCC |
9.995800E-01 |
| Normal-VS-KIRP CIMP |
4.709700E-02 |
| Normal-VS-Unclassified PRCC |
2.134800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.708000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.029800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.795200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.428440E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.894020E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.479200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.535600E-01 |
| Normal-vs-N1 |
1.078020E-01 |
| Normal-vs-N2 |
1.722230E-01 |
| N0-vs-N1 |
2.808200E-01 |
| N0-vs-N2 |
5.595800E-01 |
| N1-vs-N2 |
9.701600E-01 |
|
|
